PAI
Palo Alto Investors Portfolio holdings
AUM $470M
1-Year Return
2.57%
This Quarter Return
+16.29%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$2.37B
AUM Growth
+$232M
(+11%)
Cap. Flow
+$5.73M
Cap. Flow
% of AUM
0.24%
Top 10 Holdings %
Top 10 Hldgs %
74.03%
Holding
40
New
2
Increased
10
Reduced
8
Closed
–
Top Buys
| 1 |
Insmed
INSM
|
+$17.2M |
| 2 |
EPZM
Epizyme, Inc
EPZM
|
+$13.3M |
| 3 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$12.1M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$6.93M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$5.01M |
Top Sells
| 1 |
SAGE
Sage Therapeutics
SAGE
|
+$15.3M |
| 2 |
Gilead Sciences
GILD
|
+$14.2M |
| 3 |
United Therapeutics
UTHR
|
+$12.3M |
| 4 |
Amicus Therapeutics
FOLD
|
+$7.85M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$2.69M |
Sector Composition
| 1 | Healthcare | 94.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
1
DELISTED
Abiomed Inc
ABMD
| $326M | 13.74% |
1,935,300
-15,984
| -0.8% | -$2.69M |
|
|
CLVS
2
DELISTED
Clovis Oncology, Inc.
CLVS
| $274M | 11.56% |
3,329,581
| – | – |
|
|
3
BioMarin Pharmaceuticals
BMRN
$10.5B
| $227M | 9.56% |
2,438,519
+53,800
| +2% | +$5.01M |
|
|
4
United Therapeutics
UTHR
$18.2B
| $207M | 8.7% |
1,762,650
-104,665
| -6% | -$12.3M |
|
|
5
Insmed
INSM
$30.7B
| $193M | 8.11% |
6,171,816
+550,000
| +10% | +$17.2M |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $152M | 6.38% |
1,080,342
+49,400
| +5% | +$6.93M |
|
|
EPZM
7
DELISTED
Epizyme, Inc
EPZM
| $122M | 5.13% |
6,398,296
+700,000
| +12% | +$13.3M |
|
|
8
Amicus Therapeutics
FOLD
$2.45B
| $112M | 4.71% |
7,420,288
-520,500
| -7% | -$7.85M |
|
9
Vanda Pharmaceuticals
VNDA
$261M
| $74.4M | 3.13% |
4,155,670
-47,600
| -1% | -$852K |
|
10
Prothena Corp
PRTA
$440M
| $71M | 2.99% |
1,095,655
+21,700
| +2% | +$1.41M |
|
|
WMGI
11
DELISTED
Wright Medical Group Inc
WMGI
| $69.2M | 2.92% |
2,676,393
| – | – |
|
|
AMAG
12
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $63.5M | 2.67% |
3,441,233
+96,613
| +3% | +$1.78M |
|
13
Acadia Pharmaceuticals
ACAD
$4.14B
| $61.8M | 2.6% |
1,641,030
+27,700
| +2% | +$1.04M |
|
|
SAGE
14
DELISTED
Sage Therapeutics
SAGE
| $49M | 2.07% |
787,251
-245,774
| -24% | -$15.3M |
|
15
STAAR Surgical
STAA
$1.34B
| $43.7M | 1.84% |
3,507,052
-22,018
| -0.6% | -$274K |
|
|
CELG
16
DELISTED
Celgene Corp
CELG
| $43.1M | 1.81% |
295,240
| – | – |
|
|
IMMU
17
DELISTED
Immunomedics Inc
IMMU
| $42.1M | 1.77% |
3,010,466
| – | – |
|
18
Align Technology
ALGN
$9.44B
| $41.6M | 1.75% |
223,107
| – | – |
|
19
Karyopharm Therapeutics
KPTI
$53.6M
| $38.4M | 1.62% |
233,239
+2,067
| +0.9% | +$340K |
|
|
MNTA
20
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $33.2M | 1.4% |
1,794,998
+7,422
| +0.4% | +$137K |
|
|
AIMT
21
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $32.1M | 1.35% |
1,293,764
+4,045
| +0.3% | +$100K |
|
22
Exact Sciences
EXAS
$9.96B
| $20.4M | 0.86% |
433,076
| – | – |
|
|
SHPG
23
DELISTED
Shire pic
SHPG
| $19.9M | 0.84% |
130,200
| – | – |
|
|
24
Gilead Sciences
GILD
$139B
| $14.3M | 0.6% |
175,900
-175,700
| -50% | -$14.2M |
|
|
BIVV
25
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $12.1M | 0.51% |
+211,300
| New | +$12.1M |
|